Ambulatory intermittent rifampicin and ethambutol in the retreatment of pulmonary tuberculosis. 1974

N Sriyabhaya, and A Jittinandana, and P Kecharanantana

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004977 Ethambutol An antitubercular agent that inhibits the transfer of mycolic acids into the cell wall of the tubercle bacillus. It may also inhibit the synthesis of spermidine in mycobacteria. The action is usually bactericidal, and the drug can penetrate human cell membranes to exert its lethal effect. (From Smith and Reynard, Textbook of Pharmacology, 1992, p863) Dexambutol,EMB-Fatol,EMB-Hefa,Etambutol Llorente,Ethambutol Hydrochloride,Etibi,Miambutol,Myambutol,EMB Fatol,EMB Hefa,Hydrochloride, Ethambutol,Llorente, Etambutol
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000553 Ambulatory Care Health care services provided to patients on an ambulatory basis, rather than by admission to a hospital or other health care facility. The services may be a part of a hospital, augmenting its inpatient services, or may be provided at a free-standing facility. Outpatient Care,Outpatient Health Services,Clinic Visits,Health Services, Outpatient,Outpatient Services,Services, Outpatient Health,Urgent Care,Care, Ambulatory,Care, Outpatient,Care, Urgent,Cares, Urgent,Clinic Visit,Health Service, Outpatient,Outpatient Health Service,Outpatient Service,Service, Outpatient,Service, Outpatient Health,Services, Outpatient,Urgent Cares,Visit, Clinic,Visits, Clinic
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin

Related Publications

N Sriyabhaya, and A Jittinandana, and P Kecharanantana
July 1976, The Indian journal of chest diseases & allied sciences,
N Sriyabhaya, and A Jittinandana, and P Kecharanantana
January 1973, Scandinavian journal of respiratory diseases,
N Sriyabhaya, and A Jittinandana, and P Kecharanantana
October 1978, Problemy tuberkuleza,
N Sriyabhaya, and A Jittinandana, and P Kecharanantana
January 1973, Scandinavian journal of respiratory diseases. Supplementum,
N Sriyabhaya, and A Jittinandana, and P Kecharanantana
February 1968, Jornal brasileiro de doencas toracicas,
N Sriyabhaya, and A Jittinandana, and P Kecharanantana
June 1968, Singapore medical journal,
N Sriyabhaya, and A Jittinandana, and P Kecharanantana
April 1966, Annals of the New York Academy of Sciences,
N Sriyabhaya, and A Jittinandana, and P Kecharanantana
September 1965, Diseases of the chest,
N Sriyabhaya, and A Jittinandana, and P Kecharanantana
April 1966, Annals of the New York Academy of Sciences,
N Sriyabhaya, and A Jittinandana, and P Kecharanantana
April 1970, British journal of diseases of the chest,
Copied contents to your clipboard!